Fig. 1From: Signals of gastroesophageal reflux disease caused by incretin-based drugs: a disproportionality analysis using the Japanese adverse drug event report databaseKaplan-Meier curve of GERD-like symptom manifestation from GLP-1-RAs and DPP-4-Is. ※GERD: gastroesophageal reflux disease, GLP-1-RAs: glucagon-like peptide-1 receptor agonists, DDP-4-Is: dipeptidyl peptidase-4 inhibitorsBack to article page